CVX-060
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CVX-060, covering 2015-01-26 to 2016-01-18. Get the full timeline:
Most recent: Clinical Trial Update: PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma [Phase 2]